TLDRs;
- Israel labels chips, quantum, and bio-convergence as vital security assets, signaling deep-tech importance.
- About 10% of Israel’s high-tech workforce now focuses on semiconductor industries.
- Innovation Authority allocates $610M annually to support startups and research in strategic tech sectors.
- New bio-device R&D center aims to bridge biology, engineering, and global partnerships by 2025.
Israel is taking a bold step by positioning deep-tech sectors, semiconductors, quantum computing, and bio-convergence technologies, as core components of its national security strategy.
Dr. Alon Stopel, chairman of the Israel Innovation Authority, emphasized the need for these sectors to receive strategic attention due to their growing economic and geopolitical significance.
Speaking at the Calcalist and Discount Global Economy Conference, Stopel highlighted how these industries not only drive technological innovation but also underpin the country’s long-term security and economic competitiveness.
Chips at the Forefront of Innovation
The semiconductor industry represents a crucial segment of Israel’s high-tech ecosystem. Currently, about 10% of the nation’s high-tech workforce is employed in chip-related fields, with major firms such as Intel, Tower Semiconductor, Nova, and Camtek contributing to global supply chains.
Despite strong global demand for semiconductors, new chip startups have slowed, raising questions about Israel’s ability to translate its national-security ambitions into commercial growth.
Stopel pointed out that specialized talent shortages and capital-intensive requirements remain key challenges for the sector.
Funding and Infrastructure Boosts
To bridge gaps in private investment, the Israel Innovation Authority operates on an annual budget of roughly 2 billion shekels (approximately US$610 million). Part of this funding strategy includes a 250 million shekel Fund of Funds, designed to back venture capital and other investment vehicles that support early-stage deep-tech companies.
Additionally, entrepreneurship programs provide grants covering up to 70% of project budgets for small initiatives and 50% for larger projects, fostering co-development opportunities across universities, non-profits, medical institutions, and incubators.
These programs typically run for 12 to 36 months and focus on chips, quantum computing, and bio-convergence technologies.
Merging Biology and Engineering
Bio-convergence, where biology, engineering, and computational sciences intersect, has emerged as a strategic frontier for Israel.
A dedicated bio-device R&D infrastructure center, under construction with an investment of 113 million shekels (75 million of which comes from the Innovation Authority), is expected to open in 2025.
The facility aims to enable collaborative research for both domestic companies and international life sciences or semiconductor tool vendors, offering a platform to translate advanced biological concepts into practical, engineering-driven solutions.
Looking Ahead
While the national-security classification underscores Israel’s commitment to deep-tech, commercial pathways for growth remain complex. Long research and development cycles, significant capital requirements, and specialized talent shortages present ongoing hurdles.
Nevertheless, Stopel’s vision signals a deliberate shift toward deep-tech as a central driver of economic resilience and global technological leadership. With targeted funding, infrastructure, and co-development programs, Israel is laying the groundwork for a robust deep-tech ecosystem that supports both innovation and national security imperatives.
